Baseline | 1 month | 2 months | 3 months | Every 1 month | Every 3 months | Discontinuation of therapy | |
---|---|---|---|---|---|---|---|
Informed consent | ○ | ||||||
Medical history | ○ | ||||||
Confirmation of eligibility criteria | ○ | ||||||
Randomization | ○ | ||||||
Serum testosterone | ○ | ||||||
FACT-P | ○ | – | – | ○ | – | ○ | ○ |
PSAa | ○ | ○ | ○ | ○ | ○ | ○ | ○ |
Biochemical examinationa | ○ | ○ | ○ | ○ | ○ | ○ | ○ |
CT, bone scintigraphy | ○ | When progressive disease is suspectedb | ○ | ||||
Safety | ○ | ○ | ○ | ○ | ○ | ○ | ○ |
Further therapy | – | – | – | Best standard care |